Participants who are receiving or have received any other investigational agents within 14 days of enrollment
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents during the proposed treatment cycle.
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational study agents or treatment for their cancer
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents.
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents within 21 days of the first dose of study drug
Participants who are receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
STRATUM A: Participants receiving any other investigational agents
STRATUM B: Participants receiving any other investigational agents
STRATUM C: Participants receiving any other investigational agents
Participants may not be receiving any other investigational agents targeting histiocytosis
Participants who are receiving any other investigational agents, or any other anti-cancer therapy during study treatment
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants may not have received any other investigational agents in the previous 3 months
Participants who are receiving any other investigational agents
Participants who are receiving any investigational agents are not eligible
Participants receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants may not be receiving any other investigational agents for treatment of their cancer
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants receiving any other investigational agents
Participants who are receiving any other investigational agents after ASCT
Participants may not be receiving any other investigational agents nor have participated in an investigational trial within the past 4 weeks
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents within 14 days before the first dose of study drug
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
PHASE II: Participants may not be receiving any other investigational agents
Participants may not be receiving any biologics or investigational agents within 3 weeks
Participants receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants may not be receiving any other investigational anticancer agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants who are receiving concurrent therapy with other investigational agents
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants receiving any other anti-cancer or investigational agents
Participants may not be receiving other investigational agents.
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants may not be receiving any other investigational agents within 30 days of enrollment or during this study
Participants who are receiving any other investigational agents
Research participants receiving any other investigational agents
Participants who are receiving any other investigational agents; participants who are receiving standard of care induction therapy on a clinical trial may be eligible after discussion with the overall principal investigator
Participants who are receiving any other investigational agents
Participants receiving any other investigational agents
Participants who are receiving any other investigational agents within 4 weeks prior to enrollment; investigational antiretroviral agents for HIV are acceptable
Participants may not be receiving any other investigational agents for treatment of GVHD or underlying disease for at least 7 days
Participants may not be receiving investigational agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents within past 3 months
Participants may not have received any other investigational agents in the previous 3 months
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents during the study
Participants may not be receiving any other investigational agents
Participants may not be receiving any other investigational agents
Participants who are receiving any other investigational agents
Participants receiving other investigational agents
Participants who are receiving any other investigational agents
